Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Susanne Doblecki‐Lewis et al.|New England Journal of Medicine|2021Cited by 661
Distinguishing between acute and symptomatic chronic hepatitis B virus infectionToshiyuki Maruyama, David R. Milich, F. Schödel et al.|Gastroenterology|1994Cited by 78
Phase 3 Trial of mRNA-1273 during the Delta-Variant SurgeLindsey R. Baden, Jacqueline M. Miller, Hana M. El Sahly et al.|New England Journal of Medicine|2021Cited by 63
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trialRolando Pajón, F. Schödel, Yamuna Devi Paila et al.|Nature Medicine|2022Cited by 36